Interestingly, the loss of NSD2 led to a marked increase in NSD1 levels in PCa cells (Fig. 3j,m), likely suggesting that NSD1 could sustain residual oncogenic AR activity in these cells. This evidence concerns the gene NSD2 and posterior cortical atrophy.